Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT

Size: px
Start display at page:

Download "Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT"

Transcription

1 HPWET Hematopathology Consultation, MML Embed Client Hematopathology Consult REVISED INAL DIAGNOSIS Interpretation Peripheral blood, bone marrow aspirate and biopsies, bilateral iliac crests: 1. Normocellular bone marrow with morphologically normal trilineage hematopoiesis. Case Number BR No morphologic features of a myelodysplastic syndrome, a myeloproliferative neoplasm, or other primary malignant myeloid neoplasms. 3. No morphologic or immunophenotypic features of involvement by lymphoma. COMMENT The etiology of the patient's mild cytopenia is not evident from this bone marrow examination. Secondary causes such as toxic exposure, medication/drug usage, alcohol consumption, nutrional deficiency, autoimmune disorders, chronic inflammation/infection, should be considered. Correlation with cytogenetic and Next Generation Sequencing findings is suggested. MICROSCOPIC DESCRIPTION Peripheral Blood By report CBC (dated 6/22/17): Hgb 10.6 g/dl; RBC 3.56 X10(12)/L; MCV 86.2 fl; RDW 16.2 %; WBC 3.9 x10(9)/l; PLT 369 x 10(9)/L. NEUTROPHILS 62 MONOCYTES 16 EOSINOPHILS 0 METAMYELOCYTES 0 MYELOCYTES 0 BLASTS 0 OTHER CELLS 0 NRBC 0 Total s: 100 Peripheral smear: Red blood cells: White blood cells: % of Total s BR Page 1 of 6

2 Client Platelets: Bone Marrow Aspirate/Touch Imprint NEUTROPHILS 26 METAMYELOCYTES 7 MYELOCYTES 7 EOSINOPHILS 9 BLASTS 6 NORMOBLASTS 0 PROMONOCYTES 0 MONOCYTES 23 PLASMA CELLS 0 Total s: 100 Quality: ular M:E ratio: 2:3 Erythroid precursors: Normoblastic maturation. Myeloid precursors: Normal maturation without dysplastic features. Blasts not increased. Megakaryocytes: Normal cytology Lymphocytes: Not increased. Bone Marrow Biopsy/Clot Quality: Adequate ularity: Normal; 40%. Erythroid precursors: Relatively slightly increased with normal morphology. % of Total s BR Page 2 of 6

3 Client Myeloid Precursors: Relatively slightly decreased with normal morphology. Blasts not increased. Megakaryocytes: Normal quantity and morphology. Lymphocytes: No lymphoid aggregates. ANCILLARY STUDIES Iron stain, bone marrow aspirate: performed at Mayo Clinic in Rochester, MN: Storage slightly increased. Sideroblasts present. Ring sideroblasts not seen. Cytochemical stain, myeloperoxidase, bone marrow aspirate myeloperoxidase is positive. Cytochemical stain, butyrate esterase/chloroacetate esterase, bone marrow aspirate butyrate esterase is positive and chloroacetate is negative. Immunohistochemical studies, bone marrow biopsy, antibodies to CD30 and Ki67: The cells are negative for CD30 and negative for Ki67. REVISION DESCRIPTION Report reactivated to update Ancillary Studies. In Ancillary Studies the CD30 result was updated from positive to be negative. Gross Description Report electronically signed by ANGELA REESE-DAVIS I verify that I have examined all relevant slides/materials for the specimen(s) and rendered or confirmed the diagnosis. B: Received in formalin labeled with the patient's name, medical record number and "Bone marrow biopsy" is a 1.0 x 0.2 cm core of tissue. The specimen is submitted en toto in cassette #1.C: Received in formalin labeled with the patient's name, medical record number and "Bone marrow clot" is a 1.0 x 0.5 x 0.2 cm aggregate of tissue. The specimen is submitted en toto in cassette #1. Material Received A. BM654: Bone marrow 8 unstained slides B. BM654: biopsy C. BM654: clot Received: 23 Jun :46 Reported: 29 Jun :27 BR Page 3 of 6

4 Client Previously Reported As: Hematopathology Consult Interpretation Previously reported on 26 Jun 2017 at 12:27 as: INAL DIAGNOSIS Peripheral blood, bone marrow aspirate and biopsies, bilateral iliac crests: 1. Normocellular bone marrow with morphologically normal trilineage hematopoiesis. 2. No morphologic features of a myelodysplastic syndrome, a myeloproliferative neoplasm, or other primary malignant myeloid neoplasms. 3. No morphologic or immunophenotypic features of involvement by lymphoma. COMMENT The etiology of the patient's mild cytopenia is not evident from this bone marrow examination. Secondary causes such as toxic exposure, medication/drug usage, alcohol consumption, nutrional deficiency, autoimmune disorders, chronic inflammation/infection, should be considered. Correlation with cytogenetic and Next Generation Sequencing findings is suggested. MICROSCOPIC DESCRIPTION Peripheral Blood By report CBC (dated 6/22/17): Hgb 10.6 g/dl; RBC 3.56 X10(12)/L; MCV 86.2 fl; RDW 16.2 %; WBC 3.9 x10(9)/l; PLT 369 x 10(9)/L. NEUTROPHILS 62 MONOCYTES 16 EOSINOPHILS 0 % of Total s BR Page 4 of 6

5 Client METAMYELOCYTES 0 MYELOCYTES 0 BLASTS 0 OTHER CELLS 0 NRBC 0 Total s: 100 Peripheral smear: Red blood cells: White blood cells: Platelets: Bone Marrow Aspirate/Touch Imprint NEUTROPHILS 26 METAMYELOCYTES 7 MYELOCYTES 7 EOSINOPHILS 9 BLASTS 6 NORMOBLASTS 0 PROMONOCYTES 0 MONOCYTES 23 PLASMA CELLS 0 Total s: 100 Quality: ular M:E ratio: 2:3 % of Total s Erythroid precursors: Normoblastic maturation. BR Page 5 of 6

6 Client Myeloid precursors: Normal maturation without dysplastic features. Blasts not increased. Megakaryocytes: Normal cytology Lymphocytes: Not increased. Bone Marrow Biopsy/Clot Quality: Adequate ularity: Normal; 40%. Erythroid precursors: Relatively slightly increased with normal morphology. Myeloid Precursors: Relatively slightly decreased with normal morphology. Blasts not increased. Megakaryocytes: Normal quantity and morphology. Lymphocytes: No lymphoid aggregates. ANCILLARY STUDIES Iron stain, bone marrow aspirate: performed at Mayo Clinic in Rochester, MN: Storage slightly increased. Sideroblasts present. Ring sideroblasts not seen. Cytochemical stain, myeloperoxidase, bone marrow aspirate myeloperoxidase is positive. Cytochemical stain, butyrate esterase/chloroacetate esterase, bone marrow aspirate butyrate esterase is positive and chloroacetate is negative. Immunohistochemical studies, bone marrow biopsy, antibodies to CD30 and Ki67: The cells are positive for CD30 and negative for Ki67. BR Page 6 of 6

Hematopathology Case Study

Hematopathology Case Study www.medfusionservices.com Hematopathology Case Study CV3515-14 JUNE Clinical Presentation: Clinical Information: A 42 year old male with history of chronic myelogenous leukemia (CML) presents with an elevated

More information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS

More information

Myelodysplastic Syndrome Case 158

Myelodysplastic Syndrome Case 158 Myelodysplastic Syndrome Case 158 Dong Chen MD PhD Division of Hematopathology Mayo Clinic Clinical History 86 year old man Persistent borderline anemia and thrombocytopenia. His past medical history was

More information

Case Presentation No. 075

Case Presentation No. 075 Case Presentation No. 075 Session 4. Myelodysplastic Syndrome Cristina Montalvo, MD Baylor College of Medicine Houston, Texas 2007 Workshop of Society for Hematopathology and European Association for Haematopathology

More information

Bone Marrow Pathology. Part 1. R.S. Riley, M.D., Ph.D.

Bone Marrow Pathology. Part 1. R.S. Riley, M.D., Ph.D. Bone Marrow Pathology Part 1 R.S. Riley, M.D., Ph.D. Bone Marrow Pathology Bone marrow basics Red cell diseases White cell diseases Other diseases Bone Marrow Pathology Bone marrow basics Hematopoiesis

More information

Morfologia normale e patologica

Morfologia normale e patologica Morfologia normale e patologica Gina Zini Centro di Ricerca ReCAMH Dpt. Ematologia Università Cattolica S. Cuore - Roma EMATOLOGIA DI LABORATORIO: percorsi diagnostici e obiettivi clinici. Milano 11-12

More information

20/20 PATHOLOGY REPORTS

20/20 PATHOLOGY REPORTS 20/20 PATHOLOGY REPORTS Improving the Physician Experience. Enhancing the Patient Experience. We are LabTest Diagnostics. LabTest Diagnostics has a full-service laboratory with state-of-the-art equipment

More information

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematology 101 Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematocrits Plasma White cells Red cells Normal, Hemorrhage, IDA, Leukemia,

More information

Myelodysplastic Syndromes: Everyday Challenges and Pitfalls

Myelodysplastic Syndromes: Everyday Challenges and Pitfalls Myelodysplastic Syndromes: Everyday Challenges and Pitfalls Kathryn Foucar, MD kfoucar@salud.unm.edu Henry Moon lecture May 2007 Outline Definition Conceptual overview; pathophysiologic mechanisms Incidence,

More information

Bone Marrow Specimen (Aspirate and Trephine Biopsy) Proforma

Bone Marrow Specimen (Aspirate and Trephine Biopsy) Proforma Bone Marrow Specimen (Aspirate and Trephine Biopsy) Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.03). Family name Given name(s) Sex Male Female Intersex/indeterminate Date

More information

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 Vishnu V. B Reddy, MD University of Alabama at Birmingham Birmingham, AL USA 11/03/07

More information

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Case Workshop of Society for Hematopathology and European Association for Haematopathology Case 148 2007 Workshop of Society for Hematopathology and European Association for Haematopathology Robert P Hasserjian Department of Pathology Massachusetts General Hospital Boston, MA Clinical history

More information

Collected: , PM Sent: , PM Received: , PM Preliminary: , PM. Notification Status: COMPREHENSIVE DIAGNOSIS

Collected: , PM Sent: , PM Received: , PM Preliminary: , PM. Notification Status: COMPREHENSIVE DIAGNOSIS PATIENT Name:HIPAA, Compliant DOB: 03-25-1945 (60 yr) ID#: xxx-xx-0000 Sex: M Tel: xxx-xxx-xxxx SPECIMEN Your No:WS05-xxxx Case No:C05-00xxx Req. No:Txxxxx Collected: 06-08-05, PM Sent: 06-09-05, PM Received:

More information

Hematology Unit Lab 2 Review Material

Hematology Unit Lab 2 Review Material Objectives Hematology Unit Lab 2 Review Material - 2018 Laboratory Instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided

More information

2013 AAIM Pathology Workshop

2013 AAIM Pathology Workshop 2013 AAIM Pathology Workshop John Schmieg, M.D., Ph.D. None Disclosures 1 Pathology Workshop Objectives Define the general philosophy of reviewing pathology reports Review the various components of Bone

More information

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation CASE 106 Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation Gabriel C. Caponetti, MD University of Pennsylvania, US Clinical history 69, F peripheral neuropathy, refractory

More information

74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow

74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow 74y old Female with chronic elevation of Platelet count August 18, 2005 Faizi Ali, MD Hematopathology Fellow Clinical History Patient is a 74y old otherwise healthy Caucasian female with no major complaint

More information

MORPHOLOGY OF BONE MARROW ASPIRATES. Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman

MORPHOLOGY OF BONE MARROW ASPIRATES. Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman MORPHOLOGY OF BONE MARROW ASPIRATES Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman BONE MARROW ASPIRATION Sites Sternum Anterior or posterior iliac spines Aspiration from

More information

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms Myeloproliferative Neoplasms: A Case-Based Approach Disclosures No conflicts of interests regarding the topic being presented Adam M. Miller, MD PGY-4 Resident Physician Department of Pathology and Laboratory

More information

Mild Megakaryocyte Atypia in a Patient with Presumed Germline GATA2 Mutation, and Active Mycobacterial Infection.

Mild Megakaryocyte Atypia in a Patient with Presumed Germline GATA2 Mutation, and Active Mycobacterial Infection. CASE TYPE: GERMLINE MUTATIONS OR FAMILIAL SYNDROMES PREDISPOSING TO MYELOID OR LYMPHOID NEOPLASMS. Mild Megakaryocyte Atypia in a Patient with Presumed Germline GATA2 Mutation, and Active Mycobacterial

More information

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms Daniel A. Arber, MD Stanford University What is an integrated approach? What is an integrated approach? Incorporating all diagnostic

More information

Juvenile Myelomonocytic Leukemia (JMML)

Juvenile Myelomonocytic Leukemia (JMML) Juvenile Myelomonocytic Leukemia (JMML) JMML: Definition Monoclonal hematopoietic disorder of childhood characterized by proliferation of the granulocytic and monocytic lineages Erythroid and megakaryocytic

More information

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa The Role of the FBC in clinical decision making History Examination Investigations Decision 70% FBC Laboratory

More information

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal 1 0.

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal 1 0. Cell Identification Mitotic figure 212 99.5 Educational Erythrocyte precursor, abnormal BMD-02 The arrowed cell is a mitotic figure. It was correctly identified by 99.5% of the participants. A cell containing

More information

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for

More information

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16 35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will

More information

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic

More information

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEMATOCRIT Hematocrit is a measure of the percentage of the total blood volume that is made up by the red blood cells The hematocrit can be determined directly

More information

HEMATOPATHOLOGY SUMMARY REPORT RL;MMR;

HEMATOPATHOLOGY SUMMARY REPORT RL;MMR; HEMATOPATHOLOGY SUMMARY REPORT RL;MMR; Page 1 of 1 05/15/20XX HP000000-20XX 05/21/20XX (212) 123-457 (51) 32-3455 (51) 123-457 Age: 78 DOB: 0/05/19XX SS#: 45-45-45 Clinical Information: 78 y/o female with

More information

Chronic Myelomonocytic Leukemia with molecular abnormalities SH

Chronic Myelomonocytic Leukemia with molecular abnormalities SH Chronic Myelomonocytic Leukemia with molecular abnormalities SH2017-0351 Madhu P. Menon MD,PhD, Juan Gomez MD, Kedar V. Inamdar MD,PhD and Kristin Karner MD Madhu P Menon, MD, PhD Henry Ford Hospital Patient

More information

Blood Cell Identification Graded

Blood Cell Identification Graded Blood Cell Identification Graded Case History A 51-year-old female presented with dyspnea on exertion. Laboratory results were as follows: WBC=5.5 X 10 9 /L; Hgb=4.2 g/dl; Hct=13.9%; MCV=78.7fL; RDW=30;

More information

Heme 9 Myeloid neoplasms

Heme 9 Myeloid neoplasms Heme 9 Myeloid neoplasms The minimum number of blasts to diagnose acute myeloid leukemia is 5% 10% 20% 50% 80% AML with the best prognosis is AML with recurrent cytogenetic abnormality AML with myelodysplasia

More information

Myeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:

Myeloid neoplasms. Early arrest in the blast cell or immature cell we call it acute leukemia Myoid neoplasm divided in to 3 major categories: Myeloid neoplasms Note: Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories: 1. AML : Acute myeloid leukemia(stem cell with myeloid

More information

HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM

HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM Login: http://histopath.westernu.edu Histology Atlas AND Virtual Histology links. I. HEMATOLOGY - PERIPHERAL BLOOD Purpose: To be able to identify

More information

Blood Cell Identification Graded

Blood Cell Identification Graded BCP-21 Blood Cell Identification Graded Case History The patient is a 37-year-old female with a history of multiple sickle cell crises. She now presents with avascular necrosis of the left hip. Laboratory

More information

SESSION 1 Reactive cytopenia and dysplasia

SESSION 1 Reactive cytopenia and dysplasia SESSION 1 Reactive cytopenia and dysplasia Falko Fend, Tübingen & Alexandar Tzankov, Basel 1 Disclosure of speaker s interests (Potential) conflict of interest none Potentially relevant company relationships

More information

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016 NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016 Results from this proficiency test event are available at: http://www.wadsworth.org/regulatory/clep/pt/summaries SLIDE

More information

2 nd step do Bone Marrow Study If possible both the aspiration and

2 nd step do Bone Marrow Study If possible both the aspiration and Blood Malignancies-I Prof. Herman Hariman,SpPK a (KH). Ph.D.(U.K) Prof. Dr. Adikoesoema Aman, SpPK (KH) Dept. Clinpath, FK-USU First do the Full Blood Count Hb, WBCS, Platelets Morphology!! Such as blasts,

More information

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal/

Participants Identification No. % Evaluation. Mitotic figure Educational Erythrocyte precursor, abnormal/ Cell Identification BMD-09 Participants Identification No. % Evaluation Mitotic figure 233 96.7 Educational Erythrocyte precursor, abnormal/ 4 1.7 Educational dysplastic nuclear features Erythrocyte precursor

More information

ACCME/Disclosures. History. Hematopathology Specialty Conference Case #4 4/13/2016

ACCME/Disclosures. History. Hematopathology Specialty Conference Case #4 4/13/2016 Hematopathology Specialty Conference Case #4 Sherrie L. Perkins MD, PhD University of Utah ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose

More information

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Part 4 MYELOID NEOPLASMS

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Part 4 MYELOID NEOPLASMS HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD Part 4 MYELOID NEOPLASMS Introduction: o Myeloid neoplasms are divided into three major categories: o Acute

More information

Introduction. Indications for bone marrow examination. Obtaining the bone marrow biopsy

Introduction. Indications for bone marrow examination. Obtaining the bone marrow biopsy 1 Introduction Indications for bone marrow examination Bone marrow examination, including both aspiration and biopsy sampling, can be performed on virtually any patient. However, patients with coagulation

More information

EXAMPLE REPORT ONLY Contact AMS Biotechnology for current donor specific information

EXAMPLE REPORT ONLY Contact AMS Biotechnology for current donor specific information EXAMPLE REPORT ONLY Contact AMS Biotechnology for current donor specific information NAME DIAGNOSIS PROTOCOL OF EVALUATION for Chronic Lymphatic Leukemia (CLL) GENERAL INFORMATION (ALL information required!!)

More information

Notes for the 2 nd histology lab

Notes for the 2 nd histology lab Notes for the 2 nd histology lab Note : Please refer to the slides and see the morphological characteristics of each cell, as the practical exam will be in the form of figures. SLIDE #2 Erythropoiesis

More information

NUMERATOR: Patients who had baseline cytogenetic testing performed on bone marrow

NUMERATOR: Patients who had baseline cytogenetic testing performed on bone marrow Quality ID #67 (NQF 0377): Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow National Quality Strategy Domain: Effective Clinical Care

More information

MORPHOLOGY IN ACTION. Description MINI-CASE ONE OBJECTIVES. Differential Diagnosis. Laboratory Results

MORPHOLOGY IN ACTION. Description MINI-CASE ONE OBJECTIVES. Differential Diagnosis. Laboratory Results MORPHOLOGY IN ACTION Mini-case studies using morphology Bernadette Rodak, MS, MT, SH(ASCP) Professor emeritus Indiana University brodak@iupui.edu Description Mini-case studies will be used to integrate

More information

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor I. Description of the rotation: During this rotation, the resident will gain

More information

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge. Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,

More information

Hematopathology Case Study

Hematopathology Case Study Hematopathology Case Study AMP Outreach Course 2009 AMP Annual Meeting John Greg Howe Ph.D. Department of Laboratory Medicine Yale University School of Medicine November 19, 2009 HISTORY Case History An

More information

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) A multipotent stem cell that can differentiate into any of the myeloid lineage cells (RBCs, granulocytes, megakaryocytes)

More information

A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century. Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter

A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century. Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter Is cell morphology important? AML M7 CLL CD5 CD19 NHL

More information

Evaluation of Bone Marrow Biopsies and Aspirates ANNA PORWIT DEPARTMENT OF PATHOLOGY, LUND UNIVERSITY

Evaluation of Bone Marrow Biopsies and Aspirates ANNA PORWIT DEPARTMENT OF PATHOLOGY, LUND UNIVERSITY Evaluation of Bone Marrow Biopsies and Aspirates ANNA PORWIT DEPARTMENT OF PATHOLOGY, LUND UNIVERSITY DISCLOSURES NONE Learning objectives To review the rules of BMA evaluation To review the main issues

More information

CHALLENGING CASES PRESENTATION

CHALLENGING CASES PRESENTATION CHALLENGING CASES PRESENTATION Michael C. Wiemann, MD, FACP Program Co-Chair and Vice President Indy Hematology Education President, Clinical St. John Providence Physician Network Detroit, Michigan 36

More information

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do? 101 May 17, 2014 Myelodysplastic Syndrome: Let s build a definition Myelo bone marrow Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine What is bone marrow? What does bone

More information

Blood Cell Identification Graded

Blood Cell Identification Graded Blood Cell Identification Graded Case History The patient is a 20-year-old female with sickle cell disease who presents with bilateral leg pain for 3 days. She is scheduled to have bilateral hip and leg

More information

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Case Workshop of Society for Hematopathology and European Association for Haematopathology Case 24 2007 Workshop of Society for Hematopathology and European Association for Haematopathology Aliyah Rahemtullah 1, Martin K Selig 1, Paola Dal Cin 2 and Robert P Hasserjian 1 Departments of Pathology,

More information

Faculty of Medicine Dr. Tariq Aladily

Faculty of Medicine Dr. Tariq Aladily Iron deficiency anemia The most common anemia worldwide Only 10% of ingested iron is absorbed Most dietary iron occurs in meat products Absorbed in duodenum Hepcidin By inhibiting ferroportin, hepcidin

More information

EDUCATIONAL COMMENTARY BLOOD CELL IDENTIFICATION

EDUCATIONAL COMMENTARY BLOOD CELL IDENTIFICATION EDUCATIONAL COMMENTARY BLOOD CELL IDENTIFICATION Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click

More information

Case #1. 65 yo man with no prior history presented with leukocytosis and circulating blasts: Bone marrow biopsy was performed

Case #1. 65 yo man with no prior history presented with leukocytosis and circulating blasts: Bone marrow biopsy was performed Case #1 65 yo man with no prior history presented with leukocytosis and circulating blasts: WBC 187.4K/uL ; Hgb 10.0gm/dL; Platelet 68K/uL Neutrophil % 25.0% Lymphocyte % 38.0% Monocyte % 12.0% Metamyelocyte

More information

Polycthemia Vera (Rubra)

Polycthemia Vera (Rubra) Polycthemia Vera (Rubra) Polycthemia Vera (Rubra) Increased red cells Clonal Myeloid lineages also increased 2-13 cases per million Mean age: 60 years Sites of Involvement Bone marrow Peripheral blood

More information

2007 Workshop of SH/EAHP. Session 5 Therapy-related myeloid neoplasms

2007 Workshop of SH/EAHP. Session 5 Therapy-related myeloid neoplasms 2007 Workshop of SH/EAHP Session 5 Therapy-related myeloid neoplasms Classification: Key issues MDS vs. AML-M6 MDS vs. MDS/MPD Genetically defined entities Relevance of morphologic classification Clinical

More information

Blood Cell Identification Graded

Blood Cell Identification Graded Blood Cell Identification Graded Case History The patient was a five-day-old girl with an elevated unconjugated bilirubin and a weakly positive direct antiglobulin test (DAT). Her CBC showed: WBC = 11.0

More information

Extramedullary precursor T-lymphoblastic transformation of CML at presentation

Extramedullary precursor T-lymphoblastic transformation of CML at presentation Extramedullary precursor T-lymphoblastic transformation of CML at presentation Neerja Vajpayee, Constance Stein, Bernard Poeisz & Robert E. Hutchison Clinical History 30 year old man presented to the emergency

More information

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Classification of Hematologic Malignancies. Patricia Aoun MD MPH Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences

More information

When Cancer Looks Like Something Else: How Does Mutational Profiling Inform the Diagnosis of Myelodysplasia?

When Cancer Looks Like Something Else: How Does Mutational Profiling Inform the Diagnosis of Myelodysplasia? Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES r). nnmlbih UNIVERSITY OF SCIEFICE nnd TECHNOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES QUALIFICATION: BACHELOR OF MEDICAL LABORATORY SCIENCES QUALIFICATION CODE: 08BMLS

More information

MDS: Who gets it and how is it diagnosed?

MDS: Who gets it and how is it diagnosed? MDS: Who gets it and how is it diagnosed? October 16, 2010 Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine Weill Medical College of Cornell University The New York Presbyterian

More information

Hematology Measure #1: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow

Hematology Measure #1: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow Hematology Measure #1: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow This measure may be used as an Accountability measure Clinical Performance

More information

Bone marrow morphology in reactive conditions. Kaaren K. Reichard, MD Mayo Clinic Rochester

Bone marrow morphology in reactive conditions. Kaaren K. Reichard, MD Mayo Clinic Rochester Bone marrow morphology in reactive conditions Kaaren K. Reichard, MD Mayo Clinic Rochester reichard.kaaren@mayo.edu Nothing to disclose Conflict of Interest Outline of Presentation Brief introduction General

More information

Myelodysplastic Syndrome: Let s build a definition

Myelodysplastic Syndrome: Let s build a definition 1 MDS: Diagnosis and Treatment Update Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine Weill Medical College of Cornell University The New York Presbyterian Hospital Myelodysplastic

More information

Cbc with differential

Cbc with differential Cbc with differential Other tests might be necessary based on the results of the differential test and follow-up tests. Your doctor has many ways of determining and treating causes of abnormal blood cell

More information

EDUCATIONAL COMMENTARY DISTINGUISHING MORPHOLOGIC LOOK-ALIKES

EDUCATIONAL COMMENTARY DISTINGUISHING MORPHOLOGIC LOOK-ALIKES EDUCATIONAL COMMENTARY DISTINGUISHING MORPHOLOGIC LOOK-ALIKES Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE

More information

Year 2003 Paper two: Questions supplied by Tricia

Year 2003 Paper two: Questions supplied by Tricia QUESTION 65 A 36-year-old man presents in a post-ictal state after an observed generalised seizure. Full blood investigation shows: haemoglobin 0 g/l [128-175] mean corpuscular volume (MCV) 106 fl [80-7]

More information

Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP

Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS

More information

Protocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms Involving the Bone Marrow*

Protocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms Involving the Bone Marrow* Protocol for the Examination of Specimens From Patients With Hematopoietic Neoplasms Involving the Bone Marrow* Version: Protocol Posting Date: January 2018 This protocol is NOT required for accreditation

More information

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017

SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017 LEUKEMIA FORMS The guidelines and figures below are specific to Leukemia studies. The information in this manual does NOT represent a complete set of required forms for any leukemia study. Please refer

More information

FLOW CYTOMETRIC ANALYSIS OF NORMAL BONE MARROW

FLOW CYTOMETRIC ANALYSIS OF NORMAL BONE MARROW XI International Conference Hematopoiesis Immunology Budapest, June 6-7, 2014 FLO CYTOMETRIC ANALYSIS OF NORMAL BONE MARRO Bruno Brando and Arianna Gatti Hematology Laboratory and Transfusion Center Legnano

More information

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist Borderline cytopenias Dr Taku Sugai Consultant Haematologist Borderline cytopenias Neutropenia Thrombocytopenia Anaemia with normal haematinics Two recent cases of cytopenias Neutropenia ANC of more than

More information

Hematopathology Lab. Third year medical students

Hematopathology Lab. Third year medical students Hematopathology Lab Third year medical students Objectives Identify the lesion Know the specific name of the lesion Know associated disease Know relevant pathologic background Spherocytes: appear small,

More information

BLASTIC CRISIS AND MYELOFIBROSIS SIMULTANEOUS COMPLICATIONS IN A CASE OF CHRONIC MYELOCYTIC LEUKEMIA

BLASTIC CRISIS AND MYELOFIBROSIS SIMULTANEOUS COMPLICATIONS IN A CASE OF CHRONIC MYELOCYTIC LEUKEMIA BLASTIC CRISIS AND MYELOFIBROSIS SIMULTANEOUS COMPLICATIONS IN A CASE OF CHRONIC MYELOCYTIC LEUKEMIA Abstract Pages with reference to book, From 151 To 153 Khalid Hassan ( Department of Pathology (Haematology)

More information

Presented by: Dr. Giuseppe Molinaro Dr. Davide De Biase

Presented by: Dr. Giuseppe Molinaro Dr. Davide De Biase Presented by: Dr. Giuseppe Molinaro Dr. Davide De Biase Dog Spayed Female LABRADOR RETRIEVER 3 Years old VACCINATIONS ANTIPARASITIC COMMERCIAL DIET VOMITING FOR A MONTH DULLNESS WEIGHT LOSS INAPPETANCE

More information

Detection and Classification of Acute Leukemia by the Coulter STKS Hematology Analyzer

Detection and Classification of Acute Leukemia by the Coulter STKS Hematology Analyzer HEMATOPATHOLOGY Detection and Classification of Acute Leukemia by the Coulter STKS Hematology Analyzer JAMES D. HOYER, MD, 1 CATHERINE P. FISHER, MD, 1 VICKI M. SOPPA, BS, 1 KAY L. LANTIS, SH, MT(ASCP),

More information

Bone Marrow Evaluation of cases of Leukemia in Pathology Department, BJGMC, Pune

Bone Marrow Evaluation of cases of Leukemia in Pathology Department, BJGMC, Pune Original article: Bone Marrow Evaluation of cases of Leukemia in Pathology Department, BJGMC, Pune Shingade MS, Shah RN, Sontakke AR, Puranik SC Name of Institute / College: B. J. Govt. Medical College

More information

Hematology & Coagulation Practicum Objectives CLS - 647

Hematology & Coagulation Practicum Objectives CLS - 647 Hematology & Coagulation Practicum Objectives CLS - 647 The following objectives are to be completed by the student for successful completion of this clinical rotation. The objectives within the psychomotor

More information

Adult Acute leukemia. Matthew Seftel. August

Adult Acute leukemia. Matthew Seftel. August Adult Acute leukemia Matthew Seftel August 21 2007 mseftel@cancercare.mb.ca Principles 3 cases Diagnosis and classification of acute leukemia (AL) Therapy Emergencies Remission induction BMT Complications

More information

Proper Slide Preparation

Proper Slide Preparation Hematology Essentials: A Foundation for WBC Review Using Case Studies Christine Hinz, MS, MLS(ASCP) CM Proper Slide Preparation smooth, homogenous film 1/2 to 3/4 the slide length straight feather edge

More information

Leukocytosis - Some Learning Points

Leukocytosis - Some Learning Points Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful

More information

بسم هللا الرحمن الرحيم

بسم هللا الرحمن الرحيم بسم هللا الرحمن الرحيم WBCs disorders *Slide 2: - we will focus on the disorders that are related to the # of WBCs - in children the # of lymphocyte is more than it in adults,sometimes more than neutrophils

More information

Myelodysplastic/Myeloproliferative Disorders. MDS/MPD Unclassified Provisional: CMML JMML acml RARS T. K. Foucar November 2007 SH/EAHP Workshop

Myelodysplastic/Myeloproliferative Disorders. MDS/MPD Unclassified Provisional: CMML JMML acml RARS T. K. Foucar November 2007 SH/EAHP Workshop Myelodysplastic/Myeloproliferative Disorders CMML JMML acml MDS/MPD Unclassified Provisional: RARS T K. Foucar November 2007 SH/EAHP Workshop MDS/MPD: General Features Blood: Cytosis and cytopenia(s) Dysplasia

More information

EDUCATIONAL COMMENTARY DIFFERENTIATING IMMATURE PERIPHERAL BLOOD CELLS

EDUCATIONAL COMMENTARY DIFFERENTIATING IMMATURE PERIPHERAL BLOOD CELLS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Continuing Education on the left side of the

More information

Aplastic Anemia & MDS International Foundation Talk. Definition. Introduction 4/20/2012. April 2012 H. Phillip Koeffler, M.D.

Aplastic Anemia & MDS International Foundation Talk. Definition. Introduction 4/20/2012. April 2012 H. Phillip Koeffler, M.D. Aplastic Anemia & MDS International Foundation Talk April 2012 H. Phillip Koeffler, M.D. Definition Myelo Greek prefix; marrow Dysplasia abnormal morphology Can affect: RBCs WBCs Plts Introduction 1949:

More information

The spectrum of flow cytometry of the bone marrow

The spectrum of flow cytometry of the bone marrow The spectrum of flow cytometry of the bone marrow Anna Porwit Lund University Faculty of Medicine Dept. of Clinical Sciences Div. Oncology and Pathology anna.porwit@med.lu.se Disclosure of speaker s interests

More information

Bone marrow evaluation is an important diagnostic tool for evaluating

Bone marrow evaluation is an important diagnostic tool for evaluating 670 Vol. 24, No. 9 September 2002 CE Article #1 (1.5 contact hours) Refereed Peer Review KEY FACTS Bone marrow aspiration and core biopsy procedures are relatively simple, rapid, and inexpensive. The most

More information

CD34 positive dysplastic giant platelets masquerading as blasts on flow cytometry

CD34 positive dysplastic giant platelets masquerading as blasts on flow cytometry CD34+ Giant Platelets Hematopathology - September 2016 Case Study CD34 positive dysplastic giant platelets masquerading as blasts on flow cytometry Anmaar Abdul-Nabi 1,*, Yvette Reese 2, Susan Treese 2,

More information

Opportunities for Optimal Testing in the Myeloproliferative Neoplasms. Curtis A. Hanson, MD

Opportunities for Optimal Testing in the Myeloproliferative Neoplasms. Curtis A. Hanson, MD Opportunities for Optimal Testing in the Myeloproliferative Neoplasms Curtis A. Hanson, MD 2013 MFMER slide-1 DISCLOSURES: Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-2

More information

SB 6331 (scanned slide available) Keith Duncan; Mills-Peninsula Hospital 52-year-old male with painful right parotid mass.

SB 6331 (scanned slide available) Keith Duncan; Mills-Peninsula Hospital 52-year-old male with painful right parotid mass. SB 6331 (scanned slide available) Keith Duncan; Mills-Peninsula Hospital 52-year-old male with painful right parotid mass. SB 6332 Shyam Raghavan/Don Born; Stanford 77-year-old male with right

More information

COMPANY OR UNIVERSITY

COMPANY OR UNIVERSITY CONTRIBUTOR NAME Daniel Heinrich, DVM CONTRIBUTOR EMAIL dheinric@umn.edu COAUTHORS Jed Overmann, DVM, DACVP; Davis Seelig DVM, PhD, DACVP & Matthew Sturos, DVM COMPANY OR UNIVERSITY University of Minnesota

More information

Update on Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Kaaren Reichard Mayo Clinic Rochester

Update on Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Kaaren Reichard Mayo Clinic Rochester Update on Myelodysplastic Syndromes and Myeloproliferative Neoplasms Kaaren Reichard Mayo Clinic Rochester Reichard.kaaren@mayo.edu Nothing to disclose Conflict of Interest Learning Objectives Present

More information

ACCME/Disclosures 4/13/2016. Clinical History

ACCME/Disclosures 4/13/2016. Clinical History ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner

More information

Bone marrow aspiration as the initial diagnostic tool in the diagnosis of leukemia - A case study

Bone marrow aspiration as the initial diagnostic tool in the diagnosis of leukemia - A case study Original Research Article Bone marrow aspiration as the initial diagnostic tool in the diagnosis of leukemia - A case study Priyanka Poonam 1*, N.K. Bariar 2 1 Tutor, Department of Pathology, Patna Medical

More information